OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

HALLIBURTON CO (HAL) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

HAL · HALLIBURTON CO

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 11 filings · fetched 2026-11-13T18:00:43Z

Recent reported activity

0purchase rows on this page
6sale rows on this page
10matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-30Filed 2026-11-02Maxwell Michael CaseyOfficer · President - Western Hemisphere
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Shares transferred to Halliburton Company for payment for Federal tax withholding obligations on lapse of restrictions on shares issued under the Stock and Incentive Plan. Said Plan permits Reporting Person to satisfy withholding tax obligation by transferring unrestricted shares to the Issuer.

F2 The stock vested on October 29, 2026 and is related to stock granted on October 29, 2021. The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on October 29, 2026 was $35.90. Shares were withheld for tax reporting on October 30, 2026.

F3 Includes 146.199 shares of stock purchased through the Halliburton Company Employee Stock Purchase Plan for the period ending June 30, 2026.

References: F1, F2, F3

F WithholdingCommon Stock · Non-derivative7,551D35.9DirectForm 4 ↗0002107660-26-000008
2026-10-23Filed 2026-10-26Hernandez David ChristopherDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a right to receive one share of the Company common stock.

F2 The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director.

References: F1, F2

A Award / grant10/2026 Restricted Stock Units · Derivative961A0DirectForm 4 ↗0002160813-26-000005
2026-09-30Filed 2026-09-30Smith Maurice SDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The security converts to common stock on a one-for-one basis.

F2 Stock equivalents acquired under the Halliburton Company Directors' Deferred Compensation Plan reported on a pro-rata basis to reflect Issuer's Plan period. Said Plan is an ongoing securities acquisition plan.

F3 The stock equivalent units were accrued under the Company's Directors' Deferred Compensation Plan and are settled in the Company's common stock following cessation as a director.

F4 A portion of the stock equivalents are attributable to dividends and a portion are attributable to quarterly fees and are based on the closing price on September 23, 2026 of $33.01 and September 29, 2026 of $31.54.

F5 Each restricted stock unit represents a right to receive one share of the Company common stock.

F6 The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director.

F7 Includes stock equivalent units through September 30, 2026.

References: F1, F2, F4, F3

A Award / grantStock Equivalent Units · Derivative1,162.045A—DirectForm 4 ↗0001841752-26-000022
2026-08-31Filed 2026-09-01Carre EricOfficer · EVP & Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale was effected pursuant to a Rule 10b5-l trading plan adopted by the Reporting Person on May 19, 2026.

F2 Includes 361.118 shares of stock accumulated through dividend reinvestment as of August 31, 2026.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative24,777D37.5DirectForm 4 ↗0001673421-26-000014
2026-08-19Filed 2026-08-20Slocum Jeffrey ShannonDirector · Officer · Director, EVP and COO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale was effected pursuant to a Rule 10b5-l trading plan adopted by the Reporting Person on May 8, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.43, inclusive. The Reporting Person undertakes to provide to Halliburton Company, any security holder of Halliburton Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative52,572D35.09DirectForm 4 ↗0001970357-26-000016
2026-08-18Filed 2026-08-19Slocum Jeffrey ShannonDirector · Officer · Director, EVP and COO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale was effected pursuant to a Rule 10b5-l trading plan adopted by the Reporting Person on May 8, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.255, inclusive. The Reporting Person undertakes to provide to Halliburton Company, any security holder of Halliburton Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative16,121D35.083DirectForm 4 ↗0001970357-26-000014
2026-08-18Filed 2026-08-19Miller Jeffrey AllenDirector · Officer · Director, President & CEO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale was effected pursuant to a Rule 10b5-l trading plan adopted by the Reporting Person on May 13, 2026.

F2 Includes 844.595 shares of stock purchased through the Halliburton Company Employee Stock Purchase Plan for the period ending March 31, 2026.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative124,483D35DirectForm 4 ↗0001558667-26-000020
2026-06-30Filed 2026-06-30Smith Maurice SDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The security converts to common stock on a one-for-one basis.

F2 Stock equivalents acquired under the Halliburton Company Directors' Deferred Compensation Plan reported on a pro-rata basis to reflect Issuer's Plan period. Said Plan is an ongoing securities acquisition plan.

F3 The stock equivalent units were accrued under the Company's Directors' Deferred Compensation Plan and are settled in the Company's common stock following cessation as a director.

F4 A portion of the stock equivalents are attributable to dividends and a portion are attributable to quarterly fees and are based on the closing price on March 25, 2026 of $38.63, June 24, 2026 of $33.90, and June 29, 2026 of $34.09.

F5 Each restricted stock unit represents a right to receive one share of the Company common stock.

F6 The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director.

F7 Includes stock equivalent units through June 30, 2026.

References: F1, F2, F4, F3

A Award / grantStock Equivalent Units · Derivative1,079.638A—DirectForm 4 ↗0001841752-26-000015
2026-06-18Filed 2026-06-22Carre EricOfficer · EVP & Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale was effected pursuant to a Rule 10b5-l trading plan adopted by the Reporting Person on March 18, 2026.

F2 Includes 243.855 shares of stock accumulated through dividend reinvestment as of June 22, 2026.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative24,778D35.89DirectForm 4 ↗0001673421-26-000012
2026-05-15Filed 2026-05-18Beckwith Van H.Officer · EVP, Secretary and CLO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The sale was effected pursuant to a Rule 10b5-l trading plan adopted by the Reporting Person on August 13, 2025.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.15 to $41.38, inclusive. The Reporting Person undertakes to provide to Halliburton Company, any security holder of Halliburton Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

References: F1, F2

S Sale (market/private)Common Stock · Non-derivative198,349D41.29DirectForm 4 ↗0001832674-26-000016

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.